Skip to main content

Table 1 Healthcare resource use by percentage of patients using the resource (1a) and by annual frequency (1b)

From: Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain

 

Locorregional relapse

Metastatic relapse

1L

2L

3L

4L + 

a Health resource (percentage of patients

ED visits

30.0%

38.6%

51.4%

61.4%

64.3%

Hospitalizations

17.1%

21.3%

35.0%

45.0%

55.7%

Visit to day hospital

55.7%

71.9%

85.7%

77.1%

65.7%

Specialist visits

100.0%

87.5%

100.0%

98.6%

97.1%

Laboratory analysis

100.0%

100.0%

100.0%

100.0%

100.0%

Bone scintigraphy

13.6%

20.0%

17.9%

19.3%

17.1%

PET/CT-scan

35.0%

11.4%

7.1%

5.7%

4.3%

Bone X-ray

27.3%

45.7%

52.9%

52.9%

58.6%

Nuclear magnetic resonance

43.6%

27.9%

34.3%

32.1%

27.1%

CT scan (Brain)

0.0%

14.3%

14.3%

14.3%

14.3%

CT scan (Others)

97.1%

99.3%

99.3%

99.3%

97.1%

b) Health resource (annual frequency)

ED visits

2.0

2.4

2.9

3.6

3.7

Hospitalizations

5.3

5.1

6.6

7.6

8.6

Visit to day hospital

(oral / IV treatments)

6.4 /

17.0

12.0/17.0

12.0/17.0

12.0 / 17.0

12.0 / 17.0

Specialist visits

(oral / IV treatments)

6.4/

17.0

12.0/17.0

12.0/17.0

12.0 / 17.0

12.0 / 17.0

Laboratory analysis

(oral / IV treatments)

6.4/

17.0

12.0/17.0

12.0/17.0

12.0/17.0

12.0/17.0

Bone scintigraphy

1.2

1.7

1.4

1.5

1.3

PET/CT-scan

1.0

0.7

0.7

0.6

0.4

Bone X-ray

2.6

2.4

2.9

2.6

3.2

Nuclear magnetic resonance

1.7

2.3

1.7

1.9

1.6

CT scan (Brain)

0.0

0.4

0.4

0.4

0.4

CT scan (Others)

3.7

4.1

4.1

3.9

4.0

  1. 1L first-line; 2L second-line; 3L third-line; 4L forth-line; PET/CT-scan positron emission tomography/computed tomography; ED emergency department